Estados Unidos · Bolsa y Finanzas · The Wall Street Journal

How a Top Diabetes Nonprofit Reined In Its Venture-Capital Arm

Publicado por The Wall Street Journal · Estados Unidos hace 11 h

The venture arm of diabetes research nonprofit Breakthrough T1D was ramping up its efforts to raise $150 million to propel new treatments to market when its leadership collapsed…

Leer el artículo completo en The Wall Street Journal Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.wsj.com)

How a Top Diabetes Nonprofit Reined In Its Venture-Capital Arm

También te puede interesar

Thursday’s Economic Calendar

Trump’s New Tariffs Get a Familiar Day in Court

CFTC seeks to define event contracts as swaps amid prediction market fight

Investors thought they were buying pre-IPO OpenAI and SpaceX shares. Their cash went to strip clubs, Bloomingdale’s, and shopping on Amazon, SEC alleges

Read the letter Trump is sending along with $500 checks to nearly 1 million Americans for ACA 'refunds'

Iran’s Disappearing Oil Is Becoming Everyone’s Problem

How a Top Diabetes Nonprofit Reined In Its Venture-Capital Arm

Compartir

También te puede interesar

Thursday’s Economic Calendar

Trump’s New Tariffs Get a Familiar Day in Court

CFTC seeks to define event contracts as swaps amid prediction market fight

Investors thought they were buying pre-IPO OpenAI and SpaceX shares. Their cash went to strip clubs, Bloomingdale’s, and shopping on Amazon, SEC alleges

Read the letter Trump is sending along with $500 checks to nearly 1 million Americans for ACA 'refunds'

Iran’s Disappearing Oil Is Becoming Everyone’s Problem